Kanon Armstrong

550 Flips | 2 Magazines | 2 Likes | 2 Following | 2,253 Followers | @karmstrong25 | Husband, Father, Marketer

Doctors taking a shine to biosimilars as they get experience with them

Three years ago, doctors in Europe displayed grave doubts about using biosimilars instead of branded biologics on their patients. But after a couple …

Pharma

Specialty-drug spending set for double-digit leaps over the next 3 years: Express Scripts

It's no secret that drug spending is on the upswing. But don't expect the trend to die down any time soon, Express Scripts said. The PBM giant …

Express Scripts

Hospitals join drug price-fighting battalion with plans to crack down on spending

U.S. hospitals are finding creative ways to take aim at skyrocketing prices for branded and generic drugs, especially after dramatic price hikes last …

DTC ads drive traffic to pharma websites, but drugmakers have to take it from there

Patients today are armed with more information than ever, and they're looking for active roles in their treatment. How can pharma companies make sure …

Surprise proposal: Medicare wants to jump on the value-based pricing bandwagon

Doctors and cancer clinics are up in arms about a new Medicare reimbursement scheme that would cut their mark-ups on oncology drugs. But the Centers …

Pharma

A Structural and Cultural Transformation for a Patient-Focused UCB

Pharma has claimed patient-centricity for years, but Bharat Tewarie, EVP & Chief Marketing Officer at UCB, points out, “Everyone talks about it, but …

Janssen Leads on Patient-Centric Innovation

Janssen Healthcare Innovation, an entrepreneurial group within Janssen, the Pharmaceutical Companies of Johnson & Johnson, triumphed at last year's …

Deloitte Suggests Attempts to Move “Beyond the Pill” Successful

Looking ahead to 2016, global consultancy firm Deloitte throws the spotlight on three key issues for pharma companies as they enter the New Year: …

How to Achieve Digital Pharma Marketing Results: Dealing with Disruption

"Disruption creates opportunity for those who embrace change," begins the blurb for the book <i>RESULTS: The Future of Pharmaceutical and Healthcare</i> …

Digital Disruption

OVERVIEW<p>Get the latest Accenture Strategy insights at the intersection of Business and Technology.<p>What’s your organization’s pace in this digital …

Life Sciences Consulting

Anne O’Riordan is the senior managing director of Accenture’s Life Sciences industry group with responsibility for growing and developing the global …

Drug price increases saw 'high water mark' year in 2015: Analysts

Price hikes have landed pharma in hot water lately, with lawmakers, the public and presidential hopefuls lashing out at companies over skyrocketing …

Pharma

UPDATED: Congressional reps urge the NIH to 'march in' on rising drug prices

Up in arms about rising drug prices, a cadre of lawmakers have called for Congressional action. But the lawmaking process won't happen quickly enough …

U.S. Department of Health and Human Services

What can Gilead, Biogen and Celgene teach Big Pharma about R&D?

<i>Deloitte's Neil Lesser</i><p>For the past 5 years the biopharma experts at Deloitte have been keeping an eye on a disturbing trend that shows no sign of …

Celebrities + Social Media: Balancing Benefits and Risks

The worth of a celebrity brand spokesperson such as Phil Mickelson is based on the free publicity -- press coverage -- the celeb can generate, …

The Power of Patient Input: How FDA Learned to Love & Approve Addyi

Patients are beginning to play a much bigger role in all aspects of the pharmaceutical enterprise from drug discovery to clinical trials to FDA …

A better way to understand internal rate of return

Investments can have the same internal rate of return for different reasons. A breakdown of this metric in private equity shows why it</b> …

The essentials of innovation

Why are some big companies simply better innovators? The leaders of McKinsey’s Innovation practice, Erik Roth and Nathan Marston, explain the …

Discussions on digital: The mobile present and future

In a wide-ranging discussion, several Silicon Valley leaders discuss the next frontier for mobile, what factors influence conversion on different …

Speed and scale: Unlocking digital value in customer journeys

Even as organizations assemble digital building blocks for the long term, they also need short-term, pragmatic moves that meet customer expectations …

The role of big data in medicine

Technology is revolutionizing our understanding and treatment of disease, says the founding director of the Icahn Institute for Genomics and …

Digital Health

Digital Strategy to Drive Growth

Overview<p>Latest Thinking<p>Client Case Studies<p>LEADERSHIP<p><i>“Digital business is changing expectations and shifting value within and across industries,</i> …

It's payers vs. pharma and vice versa as Washington targets drug prices

Politicians and government officials have been turning up the heat on drug prices. Now, that pressure has pharma companies pointing the finger at …

Pharma

Pharma faces 'challenging and prolonged' reforms in China, with pricing power at risk

Big Pharma has already seen sales in China slow, thanks in part to stepped-up competition from local drugmakers. Healthcare reform there is also …

Millennial men lead the charge in seeking info from pharma marketing

Men have pharma needs, too. Traditional pharma marketing strategies target women, following common marketing wisdom that women control or influence …

What Can Pharma Learn from LinkedIn?

Many of you will have a LinkedIn account or are familiar with this popular platform. As a professional social media platform, LinkedIn provides a …

Understanding Patient Willingness to Pay

A key feature of emerging markets is that patients often have to self-fund a high proportion of their healthcare costs. For all but the most severe …

What My Burned Desk Taught Me about Pharma Growth

One day this summer I saw it; a strange burn on my desk. “What is it? And how did it get there?”, I wondered. Then the next day another one …

Focus on the Fundamentals not the Tools

Pixar is known as a Computer Generated Imagery (CGI) company but their success lies in telling great stories not in their technology. Lasseter …